Bazemore Todd
Insider CIK 1605767 · KALA SEE REMARKS, Director · PULM Director · DYAX EVP & Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALA KALA BIO, Inc. | S Sale | 2025-10-22 | 2025-10-24 | 47,768 | $0.83 | $39.6K | 35,932 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-08-29 | 2025-09-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-24 | 2025-06-26 | 4,058 | $4.01 | $16.3K | 83,699 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-06-03 | 2025-06-04 | 3,390 | $3.74 | $12.7K | 87,757 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-03-07 | 2025-03-10 | 45,200 | — | $0 | 45,200 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-01-06 | 2025-01-07 | 45,200 | — | $0 | 45,200 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 1,993 | $7.63 | $15.2K | 0 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2025-01-06 | 2025-01-07 | 10,100 | — | $0 | 0 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-06-26 | 2024-06-27 | 4,653 | $4.75 | $22.1K | 83,040 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-05-31 | 2024-06-03 | 2,093 | $6.09 | $12.7K | 87,693 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 29,300 | — | $0 | 29,300 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2024-01-04 | 2024-01-05 | 6,500 | — | $0 | 0 | SEC↗ |
| KALA KALA BIO, Inc. | S Sale | 2024-01-04 | 2024-01-05 | 1,405 | $6.74 | $9.5K | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 64,931 | — | $0 | 64,931 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-06-22 | 2023-06-23 | 48,698 | — | $0 | 84,691 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 3,499 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 3,499 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,400 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 2,199 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 4,759 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 3,439 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 864 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 499 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-05-31 | 2023-06-02 | 21,158 | — | $0 | 35,993 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-03-14 | 2023-03-15 | 576 | — | $0 | 576 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2023-01-26 | 2023-01-30 | 1,700 | — | $0 | 1,700 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-01-04 | 2023-01-06 | 12,800 | — | $0 | 14,897 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2023-01-04 | 2023-01-06 | 62 | $28.54 | $1.8K | 14,835 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-10-26 | 2022-10-28 | 214 | $6.51 | $1.4K | 2,097 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-06-27 | 2022-06-29 | 3,092 | $0.37 | $1.1K | 115,499 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2022-01-27 | 2022-01-28 | 22,100 | — | $0 | 22,100 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 3,454 | $1.30 | $4.5K | 118,591 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 238,000 | — | $0 | 238,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-10-26 | 2021-10-28 | 12,544 | $1.80 | $22.6K | 122,045 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | S Sale | 2021-06-28 | 2021-06-29 | 2,911 | $5.77 | $16.8K | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2021-01-28 | 2021-02-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2021-01-04 | 2021-01-05 | 110,000 | — | $0 | 110,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2021-01-04 | 2021-01-05 | 27,500 | — | $0 | 137,500 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-10-26 | 2020-10-28 | 81,000 | — | $0 | 110,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2020-10-22 | 2020-10-28 | 40 | $7.60 | $304 | 42 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-10-01 | 2020-10-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-06-25 | 2020-06-29 | 19,000 | — | $0 | 29,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2020-06-05 | 2020-10-28 | 2 | $13.39 | $27 | 2 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2020-03-16 | 2020-03-17 | 10,000 | $5.75 | $57.5K | 10,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 120,000 | — | $0 | 120,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-10-12 | 2019-10-15 | 175,000 | — | $0 | 175,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-01-02 | 2019-01-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-02-07 | 2018-02-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-11-20 | 2017-11-21 | 172,000 | $19.60 | $3.37M | 172,000 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 193,250 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 250,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer | 2016-01-22 | 2016-01-22 | 13,750 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2015-08-18 | 2015-08-19 | 13,750 | — | $0 | 193,250 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2015-08-18 | 2015-08-19 | 13,750 | $6.80 | $93.5K | 13,750 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2015-08-05 | 2015-08-06 | 10,000 | — | $0 | 207,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2015-08-05 | 2015-08-06 | 10,000 | $6.80 | $68.0K | 10,000 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2015-08-05 | 2015-08-06 | 10,000 | $23.53 | $235.3K | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2015-08-04 | 2015-08-06 | 33,000 | — | $0 | 217,000 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2015-08-04 | 2015-08-06 | 33,000 | $23.65 | $780.5K | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2015-08-04 | 2015-08-06 | 33,000 | $6.80 | $224.4K | 33,000 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2015-02-18 | 2015-02-20 | 250,000 | — | $0 | 250,000 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2014-04-16 | 2014-04-18 | 250,000 | — | $0 | 250,000 | SEC↗ |